| Ytd | -16.54% | |
| 1y | -28.91% |
| Open | 9.38 | Prev Close | 9.38 | Low | 9.37 | High | 9.64 | Mkt Cap | 1.90B |
| Vol | 8.47M | Avg Vol | 5.06M | EPS | -2.73 | P/E | N/A | Forward P/E | 6.33 |
| Beta | 0.85 | Short Ratio | 5.14 | Inst. Own | 117.86% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 12-26 | Earning | 11-05 | 50-d Avg | 11.97 | 200-d Avg | 11.72 | 1yr Est | 13.53 |
Shares of DENTSPLY SIRONA Inc. (NASDAQ: XRAY - Get Free Report) hit a new 52-week low on Friday. The
Engineers Gate Manager LP boosted its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) by 4
XRAY's digital dentistry, R&D and restructuring support growth, but CAD/CAM, implants, SureSmile and
BMO Capital analyst Vik Chopra maintains Dentsply Sirona (NASDAQ:XRAY) with a Market Perform and
XRAY beat Q2 earnings and revenue estimates, held 2026 guidance and improved cash flow, but falling
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or ob
CHARLOTTE, N.C., Sept. 03, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "
"I'll give you 950 billion reasons to buy bonds right now," says Thomas Hayes, who gives a contraria
Barclays analyst Glen Santangelo maintains Dentsply Sirona (NASDAQ:XRAY) with a Underweight and r
New system completes the Surity™ portfolio of external catheters for both men and women Integrates
Empowered Funds LLC increased its holdings in DENTSPLY SIRONA Inc. (NASDAQ: XRAY) by 515.3% in the f
DENTSPLY SIRONA NASDAQ: XRAY reported second-quarter 2026 revenue of $898 million, down 4.1% on a re
DENTSPLY SIRONA's Q2 sales fall 4.1% as dental weakness offsets Wellspect growth, while margins impr
The headline numbers for Dentsply (XRAY) give insight into how the company performed in the quarter
DENTSPLY SIRONA Inc. (XRAY) Q2 2026 Earnings Call Transcript
Dentsply International (XRAY) came out with quarterly earnings of $0.52 per share, beating the Zacks
Dentsply Sirona (NASDAQ:XRAY) affirms FY2026 Adj EPS guidance from $1.40-$1.50 to $1.40-$1.50 vs $1.
Dentsply Sirona (NASDAQ:XRAY) reported quarterly earnings of $0.52 per share which beat the analyst
News Summary Reported net sales of $898 million Delivered GAAP gross margin of 54.9%, GAAP diluted e
Arkadios Wealth Advisors acquired a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) in
XRAY's Q2 results are likely to reflect transformation investments, dealer inventory cuts and weak i
Dimensional Fund Advisors LP increased its position in shares of DENTSPLY SIRONA Inc. (NASDAQ: XRAY)
Piper Sandler analyst Jason Bednar maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and rai
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or ob
CHARLOTTE, N.C., July 28, 2026 (GLOBE NEWSWIRE) -- Dentsply Sirona, the world's largest diversified
BMO Capital initiates coverage on Dentsply Sirona (NASDAQ:XRAY) with a Market Perform rating and a
DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY), the world&
In turbulent markets, investors turn to dividend-yielding stocks. Here are analyst ratings for high-
Dentsply Sirona (NASDAQ:XRAY), the world's largest diversified manufacturer of professional dent
Mizuho analyst Steven Valiquette maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and lower
Dentsply Sirona (NASDAQ:XRAY) affirms FY2026 Adj EPS guidance from $1.40-$1.50 to $1.40-$1.50 vs $1.
Dentsply Sirona (NASDAQ:XRAY) reported quarterly earnings of $0.27 per share which missed the analys
Dentsply Sirona (NASDAQ:XRAY), the world's largest diversified manufacturer of professional dent
Citigroup analyst Daniel Grosslight initiates coverage on Dentsply Sirona (NASDAQ:XRAY) with a Se
Dentsply Sirona and Siemens Healthineers are pleased to announce that the first-ever dental-dedicate
Investors turn to dividend-yielding stocks during market turbulence. Benzinga offers latest analyst
Dentsply Sirona (XRAY) reported mixed Q4 results, missing earnings but beating sales estimates. FY20
Mizuho analyst Steven Valiquette maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and raise
Barrington Research analyst Michael Petusky maintains Dentsply Sirona (NASDAQ:XRAY) with a Outper
A sharp banking selloff gripped Wall Street on Friday, compounding a week dominated by concerns over
Autodesk Inc (ADSK) rose sharply after beating Q4 earnings & issuing strong guidance. Other gain
Wells Fargo analyst Vik Chopra maintains Dentsply Sirona (NASDAQ:XRAY) with a Equal-Weight and ra
Evercore ISI Group analyst Elizabeth Anderson maintains Dentsply Sirona (NASDAQ:XRAY) with a In-L
Baird analyst Jeffrey Johnson maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and raises t
Dentsply Sirona (NASDAQ:XRAY) is looking for FY2026 Adj EPS of $1.40-$1.50 vs $1.50 analyst estimate